USFDA approves Novartis Pluvicto to treat prostrate cancer
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Enables millions of Indians to monitor their vitals without the need of any additional device
In contrast to the digital health solutions in the market, TEngage is cloud-based, fully customizable and allows hospitals to implement modules with just the required features, keeping the deployment and operational cost in check
First PARP inhibitor to demonstrate overall survival benefit in early breast cancer
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support
This is the sixth successful USFDA audit for this facility
Subscribe To Our Newsletter & Stay Updated